Skip to content

SION SION Free cash flow yield

Free cash flow yield at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
3.3%+2.2pp
AbbVie logo
AbbVieABBV
5.2%+1.0pp
Septerna, Inc. logo
Septerna, Inc.SEPN
12.3%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
13%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-13.8%-3.1pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
6.3%+1.8pp

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

Based on trailing twelve months.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's free cash flow yield?
SION (SION) reported free cash flow yield of -4% in Q1 2026.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.